z-logo
open-access-imgOpen Access
The PARADISE‐MI trial: a new opportunity to improve the left ventricular remodelling in reperfused STEMI
Author(s) -
Bellis Alessandro,
Mauro Ciro,
Barbato Emanuele,
Trimarco Bruno,
Morisco Carmine
Publication year - 2022
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.14159
Subject(s) - medicine , cardiology , myocardial infarction , ejection fraction , heart failure , valsartan , enalapril , ramipril , ventricular remodeling , clinical endpoint , ace inhibitor , percutaneous coronary intervention , angiotensin converting enzyme , randomized controlled trial , blood pressure

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here